Foundation Medicine, Inc. (NASDAQ: FMI) and COTA, Inc. today announced
an agreement to capture and analyze comprehensive genomic, clinical
outcome, and cost data from patients who have undergone testing with
FoundationOne ® .
for Foundation Medicine Signs Data Partnership with Cancer Outcomes Tracking and Analysis (COTA, Inc.) to Inform Value-Based Cancer Treatment investment picks